Lømo J
Avdeling for immunologi, Det Norske Radiumhospital, Oslo.
Tidsskr Nor Laegeforen. 1998 Sep 20;118(22):3436-41.
Apoptosis (also called programmed cell death) is an active, regulated form of cell death that differs in a fundamental way from necrosis, the death type occurring in various diseases. Recent insight into apoptosis is changing important concepts in oncology. It has become clear that cancer cells die to a large extent by apoptosis, not necrosis, and that resistance to treatment may arise because of resistance to apoptosis. This leads to new strategies for cancer treatment: the possibility of induction of cell death in tumours, based on the triggering of molecules involved in the signalling of apoptosis, and managing treatment resistance by devising therapy targeted towards anti-apoptotic molecules within the cell. This article presents an overview of the intracellular mechanisms of apoptosis, and explains the possibilities for future therapy. A summary of the studies of treatment carried out to date is also given.
细胞凋亡(也称为程序性细胞死亡)是一种主动的、受调控的细胞死亡形式,与坏死在根本上有所不同,坏死是在各种疾病中发生的死亡类型。最近对细胞凋亡的深入了解正在改变肿瘤学中的重要概念。已经清楚的是,癌细胞在很大程度上是通过细胞凋亡而非坏死死亡的,并且对治疗的抗性可能由于对细胞凋亡的抗性而产生。这导致了癌症治疗的新策略:基于触发参与细胞凋亡信号传导的分子来诱导肿瘤细胞死亡的可能性,以及通过设计针对细胞内抗凋亡分子的疗法来应对治疗抗性。本文概述了细胞凋亡的细胞内机制,并解释了未来治疗的可能性。还给出了迄今为止所进行的治疗研究的总结。